ESMO 2017 Congress
|
View the complete ESMO 2017 Satellite Symposia Programme |
|
- Challenge Your Expert (CYE) session
- Controversy session
- Educational session
- Industry Satellite Symposium
- Joint Symposium
- Keynote Lecture
- Multidisciplinary Session
- Patient Advocacy Track
- Poster Discussion session
- Poster Display session
- Presidential Symposium
- Proffered Paper and Poster Discussion session
- Proffered Paper session
- Special Session
- Special Symposium
- Young Oncologist Brunch
- Young Oncologist Special session
- 08:00
- 09:00
- 10:00
- 11:00
- 12:00
- 13:00
- 14:00
- 15:00
- 16:00
- 17:00
- 18:00
- 19:00
- 20:00
Madrid Auditorium
Barcelona Auditorium
Sevilla Auditorium
- 09:15(1h 30m)Controversial issues in the neoadjuvant approach to early breast cancer
- 11:00(1h 30m)Gastrointestinal tumours, colorectal 1
- 14:45(1h 30m)How to manage ovarian cancer in 2017
- 13:00(1h 30m)Industry Satellite Symposium 13
- 18:30(1h 30m)Industry Satellite Symposium 21
- 16:30(1h 30m)Pancreatic cancer
Pamplona Auditorium
Cordoba Auditorium
- 13:00(1h 30m)Industry Satellite Symposium 15
- 18:30(1h 30m)Industry Satellite Symposium 23
- 11:00(1h 30m)Mechanisms of intrinsic and acquired resistance to current treatment strategies
- 09:15(1h 30m)Predictive biomarkers for response to immunotherapy
- 16:20(1h 40m)Supportive and palliative care
- 15:00(1h)Vomiting: One symptom, many causes
Granada Auditorium
- 16:30(1h 30m)Basic science
- 13:00(1h 30m)Industry Satellite Symposium 16
- 18:30(1h 30m)Industry Satellite Symposium 24
- 08:00(1h)Is trastuzumab single agent obsolete in early breast cancer
- 09:15(1h)Prostate cancer liquid biopsies: Ready for prime time?
- 11:00(1h 30m)Sarcoma
- 14:45(1h 30m)The incoming wave of biosimilars in oncology
Valencia Auditorium
- 15:00(1h)Brain progression on targeted therapies and immunotherapies
- 13:00(1h 30m)Industry Satellite Symposium 17
- 18:30(1h 30m)Industry Satellite Symposium 25
- 11:00(1h)Lymph involvement in GU cancer
- 09:30(1h)Midgut neuroendocrine tumour progressing on 1st line somatostatin analog: What treatment approach?
- 16:30(1h 30m)State of the science of targeted treatment in sarcoma
Tarragona Auditorium
- 09:15(1h 30m)Access to novel targeted therapies and clinical trials in Europe
- 14:45(1h 30m)ESMO-ESTRO: Lung cancer: Recent development of multimodal treatments
- 11:00(1h 30m)Immunotherapy and targeted therapies in lymphomas
- 13:00(1h 30m)Industry Satellite Symposium 18
- 18:30(1h 30m)Industry Satellite Symposium 26
- 16:30(1h 15m)Public health policy and health economics
Bilbao Auditorium
- 16:30(1h)CNS tumours
- 11:00(1h 30m)ESMO-IPOS: Working together to prevent professional burnout and improve patient care
- 14:45(1h 30m)ESMO-SIOPE: Tumours at the edge of paediatric and adult oncology: Emphasising collaboration
- 08:00(1h)Germline aberrations and prostate cancer
- 13:00(1h 30m)Industry Satellite Symposium 19
- 18:30(1h 30m)Industry Satellite Symposium 27
- 09:15(1h 30m)Supportive and palliative care
Alicante Auditorium
Cartagena Auditorium
Salamanca Auditorium
Palma Auditorium
Room 1&2